Date updated:07-11-2007
small stocks that appear dead, and most likely are.

-
PPMD.PK
Protide Pharmaceu - $0.045
- 0.00%
- $N/A
stem cell transport and storage solution company. http://www.nsf.gov/pubs/2004/nsf0450/activities.htm Profitable company 4,000,000 shares outstanding Recent move to Chicago area from Minnesota.
People owning PPMD.PK also tend to own: AGIXCYTX
TheStreet.com Rating: No Rating What is this?

-
AGIX
Agix - $0.00
- N/A
- $N/A
severely beaten down in the cardiovascular arena. now trying to come back as a diabetes preventing medicine. with recent black box warning for the tzd's, may have a chance. Several dual application drugs looking for approval-both lipid lowering relatives looking for diabetes approval New drug may soon help type 2 diabetics NEW ORLEANS, July 9 (UPI) -- A U.S. study suggests people with type 2 diabetes might soon be able to control both their glucose and cholesterol levels with a single drug. Researchers led by Professor Vivian Fonseca at Tulane University conducted a clinical trial that demonstrated the compound colesevelam HCl, in combination with Sulfonylurea-based therapy in patients with inadequately controlled type 2 diabetes, achieved significantly reduced glucose levels versus those in the study taking a placebo. "People with uncontrolled type 2 diabetes and high cholesterol face a number of challenges in keeping their glucose levels and cholesterol in check," said Fonseca. "This study demonstrated the potential to improve two important metabolic parameters with one drug." Patients who received colesevelam HCl were shown to have significant reductions in blood sugar levels, and participants' lipid profiles in the colesevelam HCl group also showed substantial improvement over placebo. An application for the commercial production and sale of the drug is pending with the U.S. Food and Drug Administration.

-
CYTX
Cytori Therapeuti - $3.30
- -2.94%
- $3.37
stem cell harvesting and noon-hour plastic surgery company Women in Europe could be having boob jobs on their lunch breaks as early as next year, according to a scientific journal. A fast-track breast enlargement process is to be rolled out by a Californian biotech company and could be introduced across Europe by next year, the Chemistry and Industry magazine says. The procedure, called Celution, takes just over an hour and involves injecting a "super-charged'' fat mixture into breast tissue. Fat is taken from a patient's buttocks or stomach using minor liposuction under local anaesthetic. The useful stem cells are separated out and an hour later a dose of stem and regenerative cells is packaged into a cartridge ready for injection. It costs a few thousand dollars and the breasts enlarge over about six months, according to the program's creator Cytori Therapeutics. Cytori Therapeutics head of research and development Kai Pinkernel said the company's initial focus will be on reconstructive surgery in breast cancer patients. (from Fox News 7/11/2007) http://medgadget.com/archives/2006/02/the_celution_sy.html
- GroomDoom's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. Charlie Munger
- 5. Calamos Advisors
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » Albo's First Portfolio
- » Fundsonly Portfolio 1
- » rk00005
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on Nov. 10, 2009 After six straight days of gains, the markets are taking a breather today, which gives us the chance to focus our attention b...
By Roberto Pedone Posted on Nov. 9, 2009 Financial-Services Bull: Barron’s talks with Anton Schutz, portfolio manager at the Burnham Financial Industries Fund (BURFX)...
By Jonas Elmerraji Posted on Nov. 9, 2009 Last week brought investors a welcome return to gains as the S&P 500 pushed up 3.2% over the course of the last five trading d...
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some of the largest % gainers from Nov. 2, 2009. more
Analyst Upgrades for Nov. 2, 2009. Read more here. more
Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more











Comments not available